Literature DB >> 25989916

Gender differences in outpatients with anxiety disorders: the Leiden Routine Outcome Monitoring Study.

L Pesce1, T van Veen2, I Carlier2, M S van Noorden2, N J A van der Wee2, A M van Hemert2, E J Giltay2.   

Abstract

BACKGROUND: Data from the general population show higher prevalence of different anxiety disorders in women as compared with men. We analysed gender differences in a naturalistic sample of outpatients with anxiety disorders in a mental healthcare setting.
METHOD: Routine outcome monitoring data were collected from 1333 patients (age: 18-65; 63.3% women) fulfilling Diagnostic and Statistical Manual of Mental Disorders IV criteria of current anxiety disorder according to the Mini-International Neuropsychiatric Interview between 2004 through 2006. Data included Comprehensive Psychopathological Rating Scale, Brief Symptom Inventory (BSI), Short Form Health Survey (SF-36), Mood and Anxiety Symptom Questionnaire (MASQ). Chi-squared test and t-test were used to compare women with men for variables with parametric distributions, and Mann-Whitney test for non-parametric distribution. Adjustments for potential confounders (age, level of education, ethnicity and comorbidites) were made by logistic regression models (for discrete variables) or analysis of covariance.
RESULTS: The female-to-male ratio (i.e., 844 women, 489 men) for any anxiety disorder was 1.73 : 1 (95% confidence interval [CI]: 1.63-1.83), with the strongest skewness for post-traumatic stress disorder (2.80 : 1) and the smallest one for social phobia (1.18 : 1). Compared with men, women reported more severe self-rating scores on the BSI (on average, the scores were 12.3% higher on 3 of 9 subscales: somatisation, interpersonal sensitivity and anxiety), SF-36 (self-reported generic health status was lower on 5 of 8 subscales: physical functioning, social functioning, physical problems, vitality and bodily pain) and MASQ (on average, the scores were 6.6% higher on 4 of 5 subscales: anxious arousal, general distress, general distress depression, general distress anxiety). On the contrary, no gender difference was found in the severity of anxiety symptoms measured by the Brief Anxiety Scale. Women were more likely to suffer from comorbid depression and bulimia nervosa, and less likely from substance abuse.
CONCLUSIONS: In a treatment-seeking population the prevalence rate of anxiety disorders was 1.7 times higher in female compared with men. Female outpatients were more severely affected on self-rated but not on observer-rated scales.

Entities:  

Keywords:  Epidemiology; gender differences; outpatient psychiatry; panic disorder; post-traumatic stress disorder

Mesh:

Year:  2015        PMID: 25989916      PMCID: PMC6998770          DOI: 10.1017/S2045796015000414

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  44 in total

1.  Prevalence and treatment of mental disorders, 1990 to 2003.

Authors:  Ronald C Kessler; Olga Demler; Richard G Frank; Mark Olfson; Harold Alan Pincus; Ellen E Walters; Philip Wang; Kenneth B Wells; Alan M Zaslavsky
Journal:  N Engl J Med       Date:  2005-06-16       Impact factor: 91.245

2.  Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: a meta-analysis.

Authors:  Pim Cuijpers; Juan Li; Stefan G Hofmann; Gerhard Andersson
Journal:  Clin Psychol Rev       Date:  2010-06-18

3.  Sex differences in depression and anxiety disorders: potential biological determinants.

Authors:  Margaret Altemus
Journal:  Horm Behav       Date:  2006-08-22       Impact factor: 3.587

4.  Four-dimensional structure underlying scales for depression anxiety and retardation: emergence of trapped anger and scale improvements.

Authors:  Jaap G Goekoop; Edwin de Beurs; Frans G Zitman
Journal:  Compr Psychiatry       Date:  2006-12-08       Impact factor: 3.735

5.  Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness.

Authors:  Carmen P McLean; Anu Asnaani; Brett T Litz; Stefan G Hofmann
Journal:  J Psychiatr Res       Date:  2011-03-25       Impact factor: 4.791

6.  Gender differences, but no racial group differences, in self-reported psychiatric symptoms in adolescents.

Authors:  R C Casper; J Belanoff; D Offer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-04       Impact factor: 8.829

7.  Can gender differences in the prevalence of mental disorders be explained by sociodemographic factors?

Authors:  M Klose; F Jacobi
Journal:  Arch Womens Ment Health       Date:  2004-03-22       Impact factor: 3.633

8.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

9.  The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group.

Authors:  M M Weissman; R C Bland; G J Canino; S Greenwald; H G Hwu; C K Lee; S C Newman; M A Oakley-Browne; M Rubio-Stipec; P J Wickramaratne
Journal:  J Clin Psychiatry       Date:  1994-03       Impact factor: 4.384

10.  Reference values for generic instruments used in routine outcome monitoring: the Leiden Routine Outcome Monitoring Study.

Authors:  Yvonne W M Schulte-van Maaren; Ingrid V E Carlier; Frans G Zitman; Albert M van Hemert; Margot W M de Waal; Martijn S van Noorden; Erik J Giltay
Journal:  BMC Psychiatry       Date:  2012-11-21       Impact factor: 3.630

View more
  3 in total

1.  A biopsychosocial model of severe fear of COVID-19.

Authors:  Patrick Nürnberger; Dirk von Lewinski; Hans-Bernd Rothenhäusler; Celine Braun; Patrick Reinbacher; Ewald Kolesnik; Andreas Baranyi
Journal:  PLoS One       Date:  2022-02-28       Impact factor: 3.240

2.  Gender differences in psychiatric outpatients: a before and during COVID-19 pandemic study in general hospitals from China.

Authors:  Wenli He; Danhong Xu; Jiafeng Wang; Yuze Shen; Zheng Lin; Liemin Ruan; Qiaozhen Chen
Journal:  Ann Gen Psychiatry       Date:  2022-09-07       Impact factor: 3.301

3.  Toxoplasma gondii Infection and Mixed Anxiety and Depressive Disorder: A Case-Control Seroprevalence Study in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Luis Francisco Sanchez-Anguiano; Jesus Hernandez-Tinoco; Luis Omar Berumen-Segovia; Yazmin Elizabeth Torres-Prieto; Sergio Estrada-Martinez; Alma Rosa Perez-Alamos; Maria Nalleli Ortiz-Jurado; Gabriel Molotla-de-Leon; Isabel Beristain Garcia; Elizabeth Rabago-Sanchez; Oliver Liesenfeld
Journal:  J Clin Med Res       Date:  2016-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.